Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Isotechnika Pharma Obtains Notice Of ILJIN's Request For Arbitration

Isotechnika Pharma Inc. (ISA.TO: Quote) announced that it has received notification that ILJIN Life Science Co., Ltd. has submitted a request for arbitration relating to Isotechnika's termination of their Development, Distribution and License Agreement or "DDL".

"We are confident that our termination of the original DDL is valid, and are prepared for arbitration proceedings. We plan on continuing to engage companies, including ILJIN, who have expressed interest in working with us to advance our lead program," said Robert Foster, Isotechnika's CEO.

Click here to receive FREE breaking news email alerts for Isotechnika Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After moving mostly higher early in the session, stocks have continued to perform well over the course of the trading day on Thursday. The gains on the day have lifted both the Dow and the S&P 500 to new record intraday highs. Firms responding to a survey by the Federal Reserve Bank of Philadelphia indicated continued growth in regional manufacturing activity in September, although the bank said the index of activity in the sector fell from its relatively high reading in August. With new construction of multi-family homes showing a substantial pullback, the Commerce Department released a report on Thursday showing a much steeper than expected drop in U.S. housing starts in the month of August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.